HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

562.331

+14.4262.63%

Number of Gainers:24

Number of Losers:7

Number of Flat:3

PE:- -

High:573.121

Open:548.044

Low:548.044

Close:547.905

Volume:100.22M

Turnover:2.08B

Market Cap:355.30B

Float Cap:317.52B

Loading ...

MicroPort CardioFlow Merges with MicroPort CRM

EDDING GENOR (06998) Surges Nearly 9% in Late Trading as EDP167 Phase II Trial Administers First Dose

ASCLETIS-B (01672) Rises Over 6% Again as ASC30 Accelerates Global Phase III Trials; Analysts See High BD Potential

Huasheng Fund Manager Liu Li Identifies Three Key Investment Sectors for 2026

Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

IMMUNOTECH-B Plans Issuance of RMB270 Million New Convertible Bonds and RMB30 Million Notes

Immunotech Biopharm - to Issue Convertible Bonds Worth RMB270 Mln

THOMSON REUTERS

Immunotech Biopharm Announces New Convertible Bond Subscription Agreement

EDDING GENOR (06998) Allocates HK$1.41 Million for Share Buyback on February 9

Edding Genor Group Buys Back 508,500 Shares for HKD 1.41 Million in HKEX Filing

Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Specialized Industries Accelerate Formation as Tianzhu Comprehensive Bonded Zone Sees 6.5% YoY Import-Export Growth in First Month of the Year

Record $8.85 Billion Deal Ignites Pharma Sector, ETF Tops 2.75% Gain

Beihai City Conducts Pre-Spring Festival Medical Device Supervision

Chinese Biotech Leader Surges Nearly 7% on $8.8 Billion Partnership with Global Pharma Giant

Hainan Free Trade Port Achieves Full-Cycle Closure for Medical Equipment Bonded Maintenance

Decoding Investment Clues from Latest Earnings Reports of Pharma Giants

ASCLETIS-B Shares Surge Nearly 9% in Morning Session Following GIC's HK$781 Million Stake Increase

Peijia Medical Files for EU Approval of Heart Implant

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":562.3312,"timestamp":1770710952494,"preClose":547.9053,"halted":0,"volume":100222399,"delay":0,"changeRate":0.026329,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":14.425903,"latestTime":"02-10 16:00:00","open":548.04407,"high":573.12134,"low":548.04407,"amount":2084810438,"amplitude":0.045769,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"pbRate":4.825429,"peRate":-38.925182,"turnoverRate":0.003041,"increases":24,"decrements":7,"flats":2,"marketCap":355304700736,"floatMarketCap":317521455616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":573.12134,"amplitude":0.045769,"preClose":547.9053,"low":548.04407,"pbRate":"4.825429","latestPrice":562.3312,"volume":100222399,"delay":0,"open":548.04407,"prevYearClose":556.26263,"prevWeekClose":539.786,"prevMonthClose":555.241,"prevQuarterClose":556.263,"fiveDayClose":528.776,"twentyDayClose":611.809,"sixtyDayClose":627.079,"secType":"PLATE","market":"HK","turnoverRate":0.003041,"peRate":-38.925182,"marketCap":355304700736,"floatMarketCap":317521455616,"timestamp":1770710952494,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":24,"down":7,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610612006","title":"MicroPort CardioFlow Merges with MicroPort CRM","url":"https://stock-news.laohu8.com/highlight/detail?id=2610612006","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610612006?lang=en_us&edition=fundamental","pubTime":"2026-02-10 16:36","pubTimestamp":1770712603,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow has announced a strategic merger with MicroPort CRM, bringing MicroPort CRM into the MicroPort CardioFlow family. The combined capabilities of both companies aim to establish a comprehensive platform in structural heart, cardiac rhythm management, and heart failure, with the goal of accelerating access to advanced cardiovascular technologies worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL77spqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1585","02160","BK1589","00853","BK1100","BK1583"],"gpt_icon":0},{"id":"1163495197","title":"EDDING GENOR (06998) Surges Nearly 9% in Late Trading as EDP167 Phase II Trial Administers First Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=1163495197","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163495197?lang=en_us&edition=fundamental","pubTime":"2026-02-10 15:48","pubTimestamp":1770709724,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) saw its shares rise nearly 9% during late trading. At the time of writing, the stock was up 6.88%, trading at HK$2.95, with a turnover of HK$3.5091 million. On February 7, EDDING...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK4585","06998","VT","VXUS","BK1574","BK4588"],"gpt_icon":0},{"id":"1151906748","title":"ASCLETIS-B (01672) Rises Over 6% Again as ASC30 Accelerates Global Phase III Trials; Analysts See High BD Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1151906748","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151906748?lang=en_us&edition=fundamental","pubTime":"2026-02-10 14:54","pubTimestamp":1770706461,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) climbed more than 6% in Hong Kong trading, extending recent gains. At the time of writing, the stock was up 5.52% to HK$17.2, with a turnover of HK$69.458 million. The rally...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","BK1515","01477","III","VT","01672","BK1191","BK4134","BK4585","BK1574","VXUS"],"gpt_icon":0},{"id":"1194946644","title":"Huasheng Fund Manager Liu Li Identifies Three Key Investment Sectors for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1194946644","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194946644?lang=en_us&edition=fundamental","pubTime":"2026-02-10 12:20","pubTimestamp":1770697243,"startTime":"0","endTime":"0","summary":"As the Lunar New Year approaches, marking a fresh start, which sectors are poised to lead market trends with dynamic momentum, and how should investors position themselves? Huasheng Xindongli Mixed...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06978","BK4564","159992","BK1574","UFO"],"gpt_icon":0},{"id":"1137771777","title":"Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=1137771777","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137771777?lang=en_us&edition=fundamental","pubTime":"2026-02-10 11:45","pubTimestamp":1770695105,"startTime":"0","endTime":"0","summary":"Shares of innovative drug concept companies advanced broadly before the midday break. At the time of writing, CSPC PHARMA (01093) was up 7.16%, trading at HK$10.48. WUXI BIO (02269) rose 5.54% to HK$40.36. Additionally, other biopharmaceutical stocks also registered gains.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","LU1226288170.HKD","LU0320764599.SGD","LU0327786744.USD","LU0348825331.USD","BK1141","LU1794554557.SGD","LU0516422440.USD","LU3063872942.SGD","BK1161","02269","LU0456827905.SGD","IE00BZ08YT58.USD","LU0823426308.USD","LU1242518857.USD","SG9999002562.SGD","LU0067412154.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU0516422952.EUR","BK1574","LU0051755006.USD","LU0348735423.USD","LU1807302812.USD","BK1521","06978","01093","IE00B031HY20.USD","LU1242518931.SGD","LU0043850808.USD","BK1576","LU1720050803.USD","LU0572944931.SGD","IE00BZ08YR35.GBP","LU0039217434.USD","LU2039709279.SGD","LU1880383366.USD","LU0516423091.SGD","LU1226287792.SGD","LU0708995583.HKD","LU0417516902.SGD","LU0052750758.USD","IE0008369823.USD","LU1960683339.HKD","LU0456846285.SGD","LU0315179316.USD","LU0307460666.USD","LU1328277881.USD","BK1610","IE00B0JY6N72.USD","LU0072913022.USD","LU0417516738.SGD","LU0819121731.USD","LU0588546209.SGD","LU0856984785.SGD","LU0516422366.SGD","LU0140636845.USD","LU0501845795.SGD","LU0359201612.USD","LU0823426480.USD","LU1688375341.USD","SG9999002463.SGD","LU0516423174.USD","IE00BZ08YS42.EUR","LU1993786604.SGD","IE0008368742.USD","LU1152091168.USD","BK1191","LU0326950275.SGD","LU1226287529.USD","LU1226287875.USD","LU1226288253.USD","LU1152091754.HKD","LU0880133367.SGD","LU0979878070.USD","BK1589","LU0359202008.SGD","LU0314109678.HKD","LU1951186391.HKD","159992","SG9999004220.SGD","LU1813983027.USD","LU0181495838.USD","IE00B543WZ88.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"1176500753","title":"CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1176500753","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176500753?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:58","pubTimestamp":1770692300,"startTime":"0","endTime":"0","summary":"CRO concept stocks are leading the gains in Hong Kong trading. By the time of writing, VIVA BIOTECH (01873) rose 6.14% to HK$2.42, WUXI BIO (02269) increased 6.01% to HK$40.54, TIGERMED (03347)...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","SG9999002562.SGD","159992","LU1720050803.USD","LU0307460666.USD","LU0979878070.USD","LU0359202008.SGD","LU0417516738.SGD","LU1688375341.USD","LU0588546209.SGD","LU0516422366.SGD","LU2125910500.SGD","LU0856984785.SGD","LU0359201612.USD","LU2242644610.SGD","LU3063872942.SGD","06978","03347","LU0456846285.SGD","LU0326950275.SGD","LU1242518931.SGD","VXUS","VT","LU0516422440.USD","LU0823426480.USD","LU0823426308.USD","LU1880383366.USD","LU1794554557.SGD","LU0320764599.SGD","BK1574","LU0572944931.SGD","LU2045819591.USD","01873","LU0516422952.EUR","LU1046422090.SGD","LU0052750758.USD","BK1589","SG9999002463.SGD","LU0348825331.USD","BK4585","LU0819121731.USD","BK1576","BK1583","LU0051755006.USD","LU0417516902.SGD","IE00B0JY6N72.USD","BK1521","LU1242518857.USD","BK1610","LU0043850808.USD","BK1161","LU0348735423.USD","LU2039709279.SGD","LU0516423091.SGD","LU0140636845.USD","LU0181495838.USD","LU0456827905.SGD","LU0516423174.USD","LU0039217434.USD","LU0708995583.HKD","BK1141","LU0327786744.USD","02359","BK4588"],"gpt_icon":0},{"id":"1100250901","title":"IMMUNOTECH-B Plans Issuance of RMB270 Million New Convertible Bonds and RMB30 Million Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=1100250901","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100250901?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:07","pubTimestamp":1770649626,"startTime":"0","endTime":"0","summary":"IMMUNOTECH-B (06978) announced that on February 9, 2026, the company, investors, and other relevant parties entered into a subscription agreement. The company conditionally agreed to issue, and the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06978"],"gpt_icon":0},{"id":"2610659707","title":"Immunotech Biopharm - to Issue Convertible Bonds Worth RMB270 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610659707?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:55","pubTimestamp":1770648940,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z51CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2610659084","title":"Immunotech Biopharm Announces New Convertible Bond Subscription Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659084","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610659084?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:55","pubTimestamp":1770648938,"startTime":"0","endTime":"0","summary":"Immunotech Biopharm Ltd. has announced the proposed issue of new convertible bonds and a loan note under a general mandate, as part of a broader settlement involving its 2023 convertible bonds. According to the Subscription Agreement entered into on 9 February 2026, the company will issue new convertible bonds with a principal amount of RMB270 million and a loan note of RMB30 million, both for a period of 364 days. The Investor will also be granted exclusive global rights to promote, sell, research, and manufacture the company’s non-pharmaceutical products under specific regulatory statuses in the PRC , South Korea, and Japan. The transaction involves various parties, including Tan Zheng Ltd, Tan Xiao Yang Ltd, and Tan Yue Yue Ltd as Obligors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL8cPwTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06978","BK1161"],"gpt_icon":0},{"id":"1177535130","title":"EDDING GENOR (06998) Allocates HK$1.41 Million for Share Buyback on February 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1177535130","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177535130?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:25","pubTimestamp":1770643532,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) announced that on February 9, 2026, the company executed a share repurchase, spending HK$1.41 million to buy back 508,500 shares at a price of HK$2.77 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"2610653664","title":"Edding Genor Group Buys Back 508,500 Shares for HKD 1.41 Million in HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653664","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653664?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:18","pubTimestamp":1770643102,"startTime":"0","endTime":"0","summary":"Edding Genor Group Holdings Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 508,500 shares at an aggregate price of HKD 1,408,545. The repurchased shares will be held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edding Genor Group Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL85gWkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1161","06998"],"gpt_icon":0},{"id":"2610658213","title":"Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658213?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:02","pubTimestamp":1770642125,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via GlobeNewswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDLxW7q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","06855","IE00B64PRP62.GBP","BK1574","SG9999014021.USD","SG9999014039.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","SG9999014005.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK1161","LU2095319765.USD","BK4112","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"1124373983","title":"Specialized Industries Accelerate Formation as Tianzhu Comprehensive Bonded Zone Sees 6.5% YoY Import-Export Growth in First Month of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1124373983","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124373983?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:05","pubTimestamp":1770638733,"startTime":"0","endTime":"0","summary":"Pharmaceuticals and medical equipment are flowing smoothly within fully automated professional storage areas for inbound and outbound operations; trucks fully loaded with cross-border e-commerce...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"1133173483","title":"Record $8.85 Billion Deal Ignites Pharma Sector, ETF Tops 2.75% Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=1133173483","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133173483?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:50","pubTimestamp":1770637845,"startTime":"0","endTime":"0","summary":"On February 9, the Hong Kong stock market experienced a broad rebound, with the pharmaceutical sector continuing its recovery trend. IMMUNOTECH-B secured a major $8.85 billion business development...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159137","159992","520510","BK1574","06978","520880"],"gpt_icon":0},{"id":"1123199840","title":"Beihai City Conducts Pre-Spring Festival Medical Device Supervision","url":"https://stock-news.laohu8.com/highlight/detail?id=1123199840","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123199840?lang=en_us&edition=fundamental","pubTime":"2026-02-09 17:12","pubTimestamp":1770628354,"startTime":"0","endTime":"0","summary":"In preparation for the upcoming Spring Festival, market regulatory authorities in Beihai City, Guangxi, have launched a special inspection campaign to ensure the quality and safety of medical devices...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1222","09996","BK1100","09997","BK1574","159883"],"gpt_icon":0},{"id":"1185973912","title":"Chinese Biotech Leader Surges Nearly 7% on $8.8 Billion Partnership with Global Pharma Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=1185973912","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185973912?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:30","pubTimestamp":1770618647,"startTime":"0","endTime":"0","summary":"Innovent Biologics (01801.HK) announced a strategic collaboration with Eli Lilly to jointly advance the global development of innovative drugs in oncology and immunology. Under the agreement,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159992","06978","BK1574"],"gpt_icon":0},{"id":"1167705945","title":"Hainan Free Trade Port Achieves Full-Cycle Closure for Medical Equipment Bonded Maintenance","url":"https://stock-news.laohu8.com/highlight/detail?id=1167705945","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167705945?lang=en_us&edition=fundamental","pubTime":"2026-02-09 11:03","pubTimestamp":1770606180,"startTime":"0","endTime":"0","summary":"According to information from Haikou Customs, the first batch of out-of-zone bonded maintenance goods utilizing the \"exceptional measures implementation\" policy have recently completed the entire...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","09997","BK1100","09996","BK1222","BK1574","159883"],"gpt_icon":0},{"id":"1144717627","title":"Decoding Investment Clues from Latest Earnings Reports of Pharma Giants","url":"https://stock-news.laohu8.com/highlight/detail?id=1144717627","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144717627?lang=en_us&edition=fundamental","pubTime":"2026-02-09 10:31","pubTimestamp":1770604318,"startTime":"0","endTime":"0","summary":"The recent U.S. stock earnings season coincides with the release of full-year 2025 performance forecasts by some pharmaceutical companies listed in A-shares and Hong Kong stocks. Here is a summary of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515","159938"],"gpt_icon":0},{"id":"1159339612","title":"ASCLETIS-B Shares Surge Nearly 9% in Morning Session Following GIC's HK$781 Million Stake Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1159339612","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159339612?lang=en_us&edition=fundamental","pubTime":"2026-02-09 09:46","pubTimestamp":1770601588,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) rose nearly 9% during the morning trading session. At the time of writing, the stock was up 8.29%, trading at HK$16.46, with a turnover of HK$14.289 million. The price movement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","01672","VT","BK4588","BK1191","BK1515","01477","BK1574","GIC","VXUS","BK4585","BK1161"],"gpt_icon":0},{"id":"2610501349","title":"Peijia Medical Files for EU Approval of Heart Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2610501349","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610501349?lang=en_us&edition=fundamental","pubTime":"2026-02-09 09:31","pubTimestamp":1770600718,"startTime":"0","endTime":"0","summary":"Peijia Medical (HKG:9996) applied for the EU approval of its GeminiOne heart implant, according to a Hong Kong bourse filing Monday.The firm submitted the EU MDR CE mark registration application for the transcatheter for the treatment of a heart condition known as mitral regurgitation.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09996","BK1574","BK1583","BK4156","BK1100"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}